Han, Q., Wang, Q., Cui, Z., Deng, M., Ma, Y., Pang, F. (2025). Nimotuzumab combined with chemotherapy plus immunotherapy as first-line treatment for advanced esophageal squamous cell carcinoma.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.4_suppl.344